Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry

  • Jutta Bergler-Klein
  • , Nina Gotcheva
  • , Oskars Kalējs
  • , Zbigniew Kalarus
  • , Dragan Kovačić
  • , Viktor Peršić
  • , Evgeny Shlyakhto
  • , Tiina Uuetoa
  • , Menno V. Huisman
  • , Gregory Y.H. Lip
  • , Dragos Vinereanu (Corresponding Author)
  • , GLORIA-AF Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science